211 related articles for article (PubMed ID: 32062879)
1. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Wang ZM; Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
[TBL] [Abstract][Full Text] [Related]
2. [Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].
Fu MJ; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):87-91. PubMed ID: 32062877
[TBL] [Abstract][Full Text] [Related]
3. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Gkolfinopoulos S; Mountzios G
Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
[No Abstract] [Full Text] [Related]
4. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
Santana-Davila R; Chow LQ
Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
[No Abstract] [Full Text] [Related]
5. Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.
Lu S; Yu Y; Yang Y
Oncologist; 2019 Feb; 24(Suppl 1):S21-S30. PubMed ID: 30819828
[TBL] [Abstract][Full Text] [Related]
6. [Immuno-checkpoint inhibitor resistance and strategy in lung cancer].
Jiang WR; Fang LP; Chang N; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):603-606. PubMed ID: 32629564
[TBL] [Abstract][Full Text] [Related]
7. The estrogen pathway as a modulator of response to immunotherapy.
Velez MA; Burns TF; Stabile LP
Immunotherapy; 2019 Sep; 11(13):1161-1176. PubMed ID: 31361169
[TBL] [Abstract][Full Text] [Related]
8. Principles of Immunotherapy in Non-Small Cell Lung Cancer.
Hsu ML; Naidoo J
Thorac Surg Clin; 2020 May; 30(2):187-198. PubMed ID: 32327177
[TBL] [Abstract][Full Text] [Related]
9. Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.
Dong J; Li B; Zhou Q; Huang D
J Evid Based Med; 2018 Nov; 11(4):278-287. PubMed ID: 30444051
[TBL] [Abstract][Full Text] [Related]
10. Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?
Cetin B; Bilgetekin İ; Ozet A
Curr Probl Cancer; 2019 Feb; 43(1):43-53. PubMed ID: 30104030
[TBL] [Abstract][Full Text] [Related]
11. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
Socinski MA
Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
[No Abstract] [Full Text] [Related]
12. Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
Patel JD; Chmura SJ
Cancer; 2018 Jul; 124(14):2878-2880. PubMed ID: 29906817
[No Abstract] [Full Text] [Related]
13. KEYNOTE-024: Unlocking a pathway to lung cancer cure?
Rusch VW; Chaft J; Hellmann M
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1777-1780. PubMed ID: 29395215
[No Abstract] [Full Text] [Related]
14. [Biomarkers predictive of PD1/PD-L1 immunotherapy in non-small cell lung cancer].
Lupo A; Alifano M; Wislez M; Boulle G; Velut Y; Biton J; Cremer I; Goldwasser F; Leroy K; Damotte D
Rev Pneumol Clin; 2018 Oct; 74(5):339-350. PubMed ID: 30337201
[TBL] [Abstract][Full Text] [Related]
15. Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.
Awada G; Klastersky J
Curr Opin Oncol; 2018 Mar; 30(2):98-104. PubMed ID: 29303787
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy combinations emerging in non-small-cell lung cancer.
Chao YL; Pecot CV
Immunotherapy; 2018 Jun; 10(8):627-629. PubMed ID: 29882690
[No Abstract] [Full Text] [Related]
17. Finally, after decades, immune checkpoint inhibitors dethroned the standard of care of small-cell lung cancer.
Saleh K; Khalife-Saleh N; Kourie HR
Immunotherapy; 2019 Apr; 11(6):457-460. PubMed ID: 30860440
[No Abstract] [Full Text] [Related]
18. There and back again: An immunotherapy tale.
Guo Y; Krupnick AS
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1771-1774. PubMed ID: 29409610
[No Abstract] [Full Text] [Related]
19. Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?
Rassy E; Mezquita L; Remon J; Besse B
Immunotherapy; 2019 Sep; 11(13):1149-1160. PubMed ID: 31361172
[TBL] [Abstract][Full Text] [Related]
20. [Role of immunotherapy in locally advanced non-small cell lung cancer].
Levy A; Doyen J; Botticella A; Bourdais R; Achkar S; Giraud P; Du C; Naltet C; Lavaud P; Besse B; Pradère P; Mercier O; Caramella C; Planchard D; Deutsch E; Le Péchoux C
Cancer Radiother; 2020 Feb; 24(1):67-72. PubMed ID: 32037126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
